sulfasalazine has been researched along with Hypereosinophilic Syndrome in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Hypereosinophilic Syndrome: A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of EOSINOPHILS in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonanno, D | 1 |
Fedele, R | 1 |
Minciullo, P | 1 |
Quattrocchi, P | 1 |
Ferlazzo, B | 1 |
1 other study available for sulfasalazine and Hypereosinophilic Syndrome
Article | Year |
---|---|
[Idiopathic hypereosinophilic syndrome associated with rheumatoid arthritis. A case report].
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Cyclosporine; Female; Glucocorticoids; Humans; Hypereosi | 2003 |